跳至主要内容
临床试验/ISRCTN10431469
ISRCTN10431469已完成未知

Cognitive impAiRmEnt Study: Supplementation with the macular carotenoids, vitamin E and fish oil

Waterford Institute of Technology Macular Pigment Research Group0 个研究点目标入组 120 人开始时间: 2015年12月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
120

研究概览

简要总结

2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32466168/ Participants with MCI (added 10/06/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34999335/ Cognitively healthy participants (added 10/01/2022)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • MCI participants:
  • 1. Males and females aged 65 years and over
  • 2. Self or family member reported memory loss
  • 3. Functionally independent in activities of daily living (as per BADLS)
  • 4. Fulfils criteria for minimal cognitive impairment (as per RBANS)
  • 5. Consensus panel agreement on the diagnosis of MCI (where applicable)
  • Non-MCI participants:
  • 1. Males and females aged 65 years and over
  • 2. Functionally independent in activities of daily living (as per BADLS)
  • 3. Confirms absence of any cognitive impairment (as per RBANS)

排除标准

  • 1. Active depression (under active review)
  • 2. Established diagnosis of early dementia (on cognitive enhancement therapy)
  • 3. Current psychiatric illness (under active review of psychotropic medications)
  • 4. Stroke disease (clinical stroke or stroke on CT)
  • 5. Rapidly progressive or fluctuating symptoms of memory loss
  • 6. Already consuming carotenoid supplements (e.g. Macushield) or fish oil supplements (e.g. Souvenaid)
  • 7. Already on cholinesterase inhibitors or NMDA receptor antagonists
  • 8. Fish allergy
  • 9. Acute angle glaucoma

研究者

发起方
Waterford Institute of Technology Macular Pigment Research Group

相似试验

Changes in brain function among individuals with a... | 临床试验